These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 12025914

  • 1. Effect of ciprofibrate on C-reactive protein and fibrinogen levels.
    Rizos E, Kostoula A, Elisaf M, Mikhailidis DP.
    Angiology; 2002; 53(3):273-7. PubMed ID: 12025914
    [Abstract] [Full Text] [Related]

  • 2. Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.
    Rizos E, Bairaktari E, Ganotakis E, Tsimihodimos V, Mikhailidis DP, Elisaf M.
    J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):219-26. PubMed ID: 12490967
    [Abstract] [Full Text] [Related]

  • 3. Ciprofibrate versus gemfibrozil in the treatment of primary hyperlipidaemia.
    Knipscheer HC, de Valois JC, van den Ende B, Wouter ten Cate J, Kastelein JJ.
    Atherosclerosis; 1996 Jul; 124 Suppl():S75-81. PubMed ID: 8831919
    [Abstract] [Full Text] [Related]

  • 4. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores EA, González-Valdez H, Gómez Pérez FJ.
    Metabolism; 2001 Jun; 50(6):729-33. PubMed ID: 11398153
    [Abstract] [Full Text] [Related]

  • 5. Modulation of plasma fibrinogen levels by ciprofibrate and gemfibrozil in primary hyperlipidaemia.
    de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C.
    Thromb Haemost; 1997 Jan; 77(1):75-9. PubMed ID: 9031453
    [Abstract] [Full Text] [Related]

  • 6. Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemia.
    Okopien B, Cwalina L, Lebek M, Kowalski J, Zielinski M, Wisniewska-Wanat M, Kalina Z, Herman ZS.
    Int J Clin Pharmacol Ther; 2001 Dec; 39(12):551-7. PubMed ID: 11770837
    [Abstract] [Full Text] [Related]

  • 7. Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effects.
    Gajdos M, Mongiellová V, Huttová D, Cibulová L, Krivosíková Z, Spustová V, Dzúrik R.
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):651-6. PubMed ID: 11602811
    [Abstract] [Full Text] [Related]

  • 8. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients.
    Kockx M, de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C, Princen HM, Kooistra T.
    Thromb Haemost; 1997 Oct; 78(4):1167-72. PubMed ID: 9364979
    [Abstract] [Full Text] [Related]

  • 9. Ciprofibrate and lipid profile.
    Chandler HA, Batchelor AJ.
    Lancet; 1994 Jul 09; 344(8915):128-9. PubMed ID: 7912363
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia].
    Gajdos M, Fedelesova V, Mongiellova V, Cibulova L, Huttova D, Polak F, Krivosikova Z.
    Bratisl Lek Listy; 1999 Aug 09; 100(8):449-53. PubMed ID: 10645034
    [Abstract] [Full Text] [Related]

  • 11. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
    Kockx M, Princen HM, Kooistra T.
    Thromb Haemost; 1998 Dec 09; 80(6):942-8. PubMed ID: 9869165
    [Abstract] [Full Text] [Related]

  • 12. Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.
    Papadakis JA, Ganotakis ES, Jagroop IA, Winder AF, Mikhailidis DP.
    Int J Cardiol; 1999 Jun 01; 69(3):237-44. PubMed ID: 10402106
    [Abstract] [Full Text] [Related]

  • 13. CORONARY EFFECT OF FIBRATES ON PROTEINS AND ENZYMES WHICH HYDROLYZE TRIACYLGLYCEROLS.
    Francik R, Kryczyk J, Francik S.
    Acta Pol Pharm; 2016 Jun 01; 73(3):579-88. PubMed ID: 27476274
    [Abstract] [Full Text] [Related]

  • 14. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Mikhailidis DP, Jagroon IA.
    Metabolism; 2001 Nov 01; 50(11):1385-6. PubMed ID: 11715936
    [No Abstract] [Full Text] [Related]

  • 15. Effects of various fibrates on serum alkaline phosphatase activity.
    Ganotakis E, Tsimihodimos V, Bairaktari E, Rizos E, Athyros V, Seferiades C, Elisaf M.
    Atherosclerosis; 2002 Nov 01; 165(1):187-8. PubMed ID: 12208487
    [No Abstract] [Full Text] [Related]

  • 16. Abnormal lipid profiles on fibrate derivatives.
    McLeod AJ, Warren RJ, Armitage M.
    Lancet; 1996 Jan 27; 347(8996):261. PubMed ID: 8551900
    [No Abstract] [Full Text] [Related]

  • 17. Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate.
    Cignarella A, Nastasi M, Cavalli E, Puglisi L.
    Thromb Res; 1996 Dec 01; 84(5):311-22. PubMed ID: 8948058
    [Abstract] [Full Text] [Related]

  • 18. Lipid profiles on fibric-acid derivatives.
    Capps NE.
    Lancet; 1994 Sep 03; 344(8923):684-5. PubMed ID: 7915370
    [No Abstract] [Full Text] [Related]

  • 19. [The treatment of chronic ischemic heart disease: the potentials for hypolipidemic correction using current drugs].
    Tashchuk VK, Makoviĭchuk IO, Bilets'kyĭ SV, Hrechko SI, Polishchuk OIu, Turubarova NA.
    Lik Sprava; 1998 Sep 03; (5):101-3. PubMed ID: 9793321
    [Abstract] [Full Text] [Related]

  • 20. Homocysteine elevation with fibrates: is it a class effect?
    Harats D, Yodfat O, Doolman R, Gavendo S, Marko D, Shaish A, Sela BA.
    Isr Med Assoc J; 2001 Apr 03; 3(4):243-6. PubMed ID: 11344833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.